EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant

Lorenzo Giovannico, Giuseppe Fischetti, Domenico Parigino, Luca Savino, Nicola Di Bari, Aldo Domenico Milano, Massimo Padalino, Tomaso Bottio

Transplant International · 18.12.2024 · 37

DOI: 10.3389/ti.2024.12981 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant International, online erschienen am 18.12.2024. Verfasst von Lorenzo Giovannico und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, Bari, Italy. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Heart Transplantation, Heart Failure. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero Della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure is a serious and challenging medical condition characterized by the inability of the heart to pump blood effectively, leading to reduced blood flow to organs and tissues. Several underlying causes may be linked to this, including coronary artery disease, hypertension, or previous heart attacks. Therefore, it is a chronic condition that requires ongoing management and medical attention. HF affects >64 million individuals worldwide. Heart transplantation remains the gold standard of treatment for patients with end-stage cardiomyopathy. The recruitment of marginal donors may be considered an asset at the age of cardiac donor organ shortage. Primary graft dysfunction (PGD) is becoming increasingly common in the new era of heart transplantations. PGD is the most common cause of death within 30 days of cardiac transplantation. Mechanical Circulatory Support (MCS), particularly venoarterial extracorporeal membrane oxygenation (V-A ECMO), is the only effective treatment for severe PGD. VA-ECMO support ensures organ perfusion and provides the transplanted heart with adequate rest and recovery. In the new era of heart transplantation, early use allows for increased patient survival and careful management reduces complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationHeart TransplantationHeart FailureHumansPrimary Graft DysfunctionTissue Donors

Stichwörter der Autor:innen

ECMOheart diseaseheart failureheart transplantprimary graft dysfunction

Autor:innen und Institutionen

  • Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, Bari, Italy.

Förderung

  • Ministero Della Salute

Zitieren

APA

Giovannico, L., Fischetti, G., Parigino, D., Savino, L., Di Bari, N., Milano, A. D., Padalino, M., & Bottio, T. (2024). Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant. Transplant International, 37. https://doi.org/10.3389/ti.2024.12981

Vancouver

Giovannico L, Fischetti G, Parigino D, Savino L, Di Bari N, Milano AD, et al. Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant. Transplant International. 2024;37. doi:10.3389/ti.2024.12981

BibTeX
@article{Giovannico2024,
  author = {Giovannico, Lorenzo and Fischetti, Giuseppe and Parigino, Domenico and Savino, Luca and Di Bari, Nicola and Milano, Aldo Domenico and Padalino, Massimo and Bottio, Tomaso},
  title = {Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant},
  journal = {Transplant International},
  year = {2024},
  volume = {37},
  doi = {10.3389/ti.2024.12981}
}
Kostenlos starten →